ArticlePharmaceutics2022

Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis.

Ahmad Z Bahlool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.